Immunoprecise Antibodies Ltd reports results for the quarter ended in October - Earnings Summary

Mindwalk Holdings

14/12/2023 15:08

* Immunoprecise Antibodies Ltd  IPA.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
October, higher than the same quarter last year, when the
company reported EPS of -30 cents.  The mean expectation of
two analysts for the quarter was for a loss of 13 cents per
share. Wall Street expected results to range from -14 cents
to -12 cents per share.
    * Revenue rose 18.6% to C$6.15 million from a year ago;
analysts
expected C$5.85 million. 
    * Immunoprecise Antibodies Ltd's reported EPS for the
quarter was
a loss of 10 cents​.
    * The company reported a quarterly loss of C$2.62 million.
    * Immunoprecise Antibodies Ltd shares had fallen by 34.4%
this
quarter and lost 77.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 36.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Immunoprecise
Antibodies Ltd is $8.00 
This summary was machine generated from LSEG data December 14 at
03:07 p.m. UTC. ​All figures in Canadian dollars unless
otherwise stated. (For questions concerning the data in this
report, contact Estimates.Support@lseg.com. For any other
questions or feedback, contact
RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Oct. 31 2023      -0.13          -0.10          Beat
 Jul. 31 2023      -0.20          -0.14          Beat
 Apr. 30 2023      -0.17          -0.21          Missed
 Jan. 31 2023      -0.23          -0.19          Beat